What OrthoPulse does

OrthoPulse is a medical device brand operated by Biolux Technology GmbH, an Austrian private company headquartered in Absdorf with a U.S. commercial hub in New York. The company develops and markets FDA-cleared, EU MDR-approved, and Health Canada-approved intra-oral devices that deliver 850nm near-infrared photobiomodulation to accelerate orthodontic tooth movement and reduce treatment-related pain. OrthoPulse devices are designed for use with both fixed braces and clear aligner systems (notably Invisalign), requiring only 10 minutes of daily self-treatment (5 minutes per arch). The mechanism stimulates cytochrome c oxidase in cell mitochondria to increase ATP and nitric oxide production, enhancing osteoblast/osteoclast activity and bone remodeling. The portfolio includes the flagship OrthoPulse (and OrthoPulse 2.0), the newly launched OrthoPulse lite designed for broader accessibility, a patient-facing Bluetooth-paired mobile app (iOS/Android), and the OrthoPulse Connect doctor portal for compliance monitoring and treatment management.

OrthoPulse sells devices primarily through a prescription-based distribution model in which orthodontists prescribe and dispense the device to patients within their treatment plans, supported by a field sales motion targeting individual practices and orthodontic networks. A "Smart Digital Platform" revenue stream combines the hardware sale with the mobile app and doctor portal, positioning the company for recurring software/data monetization on top of device sales. Go-to-market combines direct sales, channel partnerships (notably with the Premier Orthodontic Practices (POP) network), and event-driven demand generation at industry conferences such as the AAO Annual Session. Pricing evidence is limited but includes a $275-per-unit launch package tied to a 25-unit Summer Practice Integration Program offered through June 2026.

The company is in an early commercial stage, having secured a $4.5 million seed round in November 2024 from redalpine and Revere Partners. It has expanded its leadership team with hires including a Chief Revenue Officer (Michael Hendricks), a Regional Sales Manager (Joe Cannillo), and Chairman Raphael Pascaud (formerly of DentalMonitoring and Align Technology) to drive U.S. market expansion. OrthoPulse reports over 2 million teeth cumulatively treated, claims up to 50% reduction in treatment time, 35% fewer finishing aligners, and up to 73% reduction in peak pain in clinical studies, and holds an issued patent portfolio across the U.S., Europe, China, and Japan.

Name

OrthoPulse

Legal name

Biolux Technology GmbH

Website

https://orthopulse.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

OrthoPulse (Biolux Technology GmbH) develops FDA-cleared intra-oral near-infrared light therapy devices (850nm) that accelerate orthodontic tooth movement and reduce pain for patients using braces or clear aligners, sold via prescription through orthodontic practices and supported by a patient app and doctor portal.

Ownership category

akta.pro rank

Product category

Orthodontic Medical Devices

NAICS

Dental Equipment and Supplies Manufacturing (339114), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Dental Equipment & Supplies (3843), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Clear Aligner Orthodontics (HLABABAD)

akta.pro secondary industries

Comprehensive Orthodontic Clinics (HLABABAA), Orthodontic Appliances & Aligners Fabrication (HLABAJAD)

Keywords

• Dental medical devices
• Orthodontic acceleration technology
• Photobiomodulation therapy devices
• Near-infrared light therapy
• Orthodontic practice solutions

Headquarters

HQ city

Absdorf

HQ country

Austria

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Marketing or Sales, Supply Chain, Personnel, Operations

Revenue model

1. OrthoPulse Device Sales: Sale of the OrthoPulse and OrthoPulse lite near-infrared light therapy devices to orthodontic practices and patients via prescription. The device is a medical device requiring dental professional prescription.
2. Smart Digital Platform: Digital platform supporting the device with mobile app and doctor portal services, potentially enabling ongoing relationship management and data services.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Core offering

OrthoPulse manufactures and sells FDA-cleared intra-oral medical devices that use 850nm near-infrared light (photobiomodulation) to accelerate orthodontic tooth movement and reduce treatment pain. The flagship OrthoPulse device and the newer OrthoPulse lite are sold by prescription through orthodontic practices and supported by a patient-facing mobile app and a doctor-facing web portal (OrthoPulse Connect) for treatment tracking and practice management.

Product overview

OrthoPulse is a medical device company offering light-accelerated orthodontic technology. The product portfolio consists of two device variants: the flagship OrthoPulse (2.0) and the newer OrthoPulse lite, both FDA-cleared intra-oral devices using 850nm near-infrared photobiomodulation to accelerate tooth movement and reduce treatment pain. These devices are supported by a complementary software ecosystem including a patient-facing mobile app for treatment tracking and reminders, and a doctor-facing portal (OrthoPulse Connect) for monitoring patient progress and managing treatments. The technology is clinically validated with over 6,000 peer-reviewed articles supporting its mechanism of action, which stimulates mitochondrial cytochrome c oxidase to increase ATP production and enhance bone remodeling.

Differentiator

Problem solved

Functional benefit

Brands

• OrthoPulse lite: FDA-cleared near-infrared light therapy device for accelerated orthodontic treatment, designed for scalable adoption across all orthodontic practices and treatment types.
• OrthoPulse 2.0
• OrthoPulse Connect
• Light Accelerated Orthodontics

Products and services

• OrthoPulse FDA-cleared intra-oral device using 850nm near-infrared light therapy (photobiomodulation) to stimulate bone remodeling and accelerate orthodontic tooth movement. Reduces treatment time by up to 50%, requires only 10 minutes daily (5 minutes per arch), and is compatible with both braces and clear aligners. Prescribed by orthodontists for patients undergoing orthodontic treatment.
• OrthoPulse lite FDA-cleared near-infrared orthodontic therapy device designed for broader accessibility and scalability across orthodontic practices. Delivers the same 850nm wavelength photobiomodulation as flagship OrthoPulse with simplified clinical protocols supporting biological response during tooth movement, enhanced comfort, and improved patient engagement.
• OrthoPulse Mobile App Patient-facing mobile application for iOS and Android that pairs with the OrthoPulse device via Bluetooth to track treatment progress, deliver treatment information, and send daily reminders. Supports patient engagement and adherence during orthodontic treatment with OrthoPulse devices.
• OrthoPulse Connect (Doctor Portal) Practitioner-facing web portal providing real-time data and tools for orthodontists to monitor and manage patient OrthoPulse treatments, including dashboard views of treatment progression, refinement tracking, and patient compliance monitoring across their patient base.

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Premier Orthodontic Practices (POP)coreChannel Partner/ Reseller/ Distributor · 18 February 2026Strategic partnership with POP, a network of private practice orthodontists dedicated to lowering overhead and improving operational/clinical efficiencies. The partnership expands access to FDA-cleared near-infrared light therapy for patients within the POP network across the US. POP members maintain clinical autonomy while benefiting from shared best practices and advanced clinical tools. The partnership aims to make OrthoPulse technology accessible to all orthodontic patients regardless of age, case complexity, or treatment modality.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• OrthoAccel Technologies (AcceleDent): OrthoAccel is the most direct competitor — manufactures AcceleDent, an FDA-cleared intra-oral vibratory/micro-pulse device that also claims to accelerate orthodontic tooth movement. Both companies target the same orthodontist-prescribed adjunctive therapy category.
• Propel Orthodontics: Propel offers the VPro+ vibratory appliance and Excellerator micro-osteoperforation devices marketed to orthodontists for accelerated treatment. Same orthodontic acceleration use case and orthodontist customer base as OrthoPulse.

Emerging players

• DentalMonitoring: DentalMonitoring provides AI-driven remote orthodontic monitoring software used by orthodontists and aligner companies. Partial overlap as a digital platform serving the same orthodontist customers; Raphael Pascaud's prior affiliation makes this a strategically relevant adjacent player.
• LightForce Orthodontics: LightForce provides 3D-printed custom bracket systems for orthodontic treatment, targeting practice efficiency and outcomes — overlapping value proposition (faster, more predictable treatment) with the same orthodontist customer base.
• uLab Systems: uLab offers AI-assisted orthodontic treatment planning and in-office aligner fabrication, targeting orthodontists seeking workflow efficiency. Adjacent to OrthoPulse's practice-efficiency value proposition in the same customer segment.

Broad incumbents

• Align Technology: Align Technology (Invisalign) dominates the clear aligner market and is the indirect channel for most OrthoPulse use cases. Could develop or acquire a competing acceleration technology; Raphael Pascaud's prior affiliation makes this relationship pivotal.
• 3M Oral Care ( Clarity Aligners): 3M Clarity is a clear aligner product line from a large dental conglomerate. Broad incumbent in the orthodontic appliances space that could potentially bundle or partner on acceleration-adjacent solutions.

Regional players

• Candid (Candid Health): Candid offers clear aligner treatment through a hybrid in-office/remote model. Indirect peer as a clear aligner brand that competes for the same orthodontic patient treatment dollars that OrthoPulse's value proposition attaches to.
• SmileDirectClub: SmileDirectClub is a direct-to-consumer clear aligner brand. Different distribution model (consumer-led vs. orthodontist-prescribed) but competes for the same end patient use case that OrthoPulse's technology accelerates.

Others

• Fotona (LightWalker / dental laser systems): Fotona manufactures dental lasers used for soft/hard tissue procedures, including low-level laser therapy applications explored in orthodontic acceleration research. Adjacent enabling technology provider in the light-based dental therapy category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/orthopulse.official
• LinkedInlinkedin.com/showcase/orthopulse
• Instagraminstagram.com/orthopulse_official
• Xx.com/orthopulse

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OrthoPulse